Glass House Brands (GLAS) Free Cash Flow (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Free Cash Flow of -$8.2 million for Q1 2026, down 189.56% year-over-year from $9.2 million in Q1 2025, and up 67.28% quarter-over-quarter from -$25.1 million in Q4 2025.
Glass House Brands (GLAS) Free Cash Flow (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Free Cash Flow for 7 consecutive years, with -$8.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 189.56% year-over-year to -$8.2 million; the TTM figure through Mar 2026 stood at -$2.5 million (down 109.47% YoY), while the FY2025 annual figure was $14.8 million, down 17.99% from the prior year.
- Free Cash Flow improved to -$8.2 million in Q1 2026 per GLAS's latest filing, from -$25.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $21783.2 billion in Q3 2023 and bottomed at -$15478.4 billion in Q4 2022.
- Historically, Free Cash Flow has averaged $370.9 billion across 5 years, with a median of $3.6 million in 2025.
- Annual changes were most pronounced in 2023 — Free Cash Flow jumped 207931285.36% — and 2026, when it tumbled 189.56%.
- Glass House Brands' Free Cash Flow stood at -$15478.4 billion in 2022, then soared by 100.0% to -$4.6 million in 2023, then slumped by 113.75% to -$9.8 million in 2024, then slumped by 155.03% to -$25.1 million in 2025, then surged by 67.28% to -$8.2 million in 2026.
- Business Quant data shows GLAS's Free Cash Flow at -$8.2 million in Q1 2026, -$25.1 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Glass House Brands | 831.09 Mn | 812.54 Mn | 15.77 Mn | 2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.21 Mn |
| Mar 31, 2026 | -8.21 Mn |
| Dec 31, 2025 | -25.09 Mn |
| Dec 31, 2025 | -25.09 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 27.20 Mn |
| Jun 30, 2025 | 27.20 Mn |
| Mar 31, 2025 | 9.17 Mn |
| Mar 31, 2025 | 9.17 Mn |
| Dec 31, 2024 | -9.84 Mn |
| Dec 31, 2024 | -9.84 Mn |
| Sep 30, 2024 | 14.59 Mn |
| Sep 30, 2024 | 14.59 Mn |
| Jun 30, 2024 | 12.81 Mn |
| Jun 30, 2024 | 12.81 Mn |
| Mar 31, 2024 | 530,000.00 |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | -4.60 Mn |
| Dec 31, 2023 | -4.60 Mn |